9
Total investments
3
Early stage
2
Mid stage
1
Late stage
3y
Years active
Portfolio
9 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Jan 2026
Aisy’s AI-native threat model intelligence platform turns overwhelming vulnerability data into clear, attacker-driven priorities that free up your team to focus on real risk.
Investor + Board
Jan 2026
At AgileRL, we are on a mission to accelerate reinforcement learning for building superhuman artificial intelligence systems. Backed by Fusion Fund, Flying Fish, Octopus Ventures, Counterview Capital and Entrepreneur First.
We believe that reinforcement learning will form a part of every sophisticated AI system of the future. It already impacts the world we live in, from its use in creating LLMs with reasoning capabilities, to enabling autonomous vehicles to make decisions. Reinforcement learning enables AI models to plan and achieve objectives, but currently very few companies or individuals have the resources to leverage this powerful machine learning paradigm.
AgileRL offers Arena, an enterprise-grade reinforcement learning operations (RLOps) platform and a state-of-the-art open-source framework to eliminate these barriers to entry. Our framework has already achieved 10x faster training and hyperparameter optimisation than leading RL libraries. Arena, built on top of our open-source framework, is focused on four key areas - simulation, training, deployment and monitoring.
Investor
Nov 2025
BluePill builds AI consumers — digital twins of real audiences trained on real-world social, survey, and research data — that think, react, and engage like your customers.
Brands use BluePill to get instant consumer insight — to test product concepts and packaging, identify winning creatives, or simulate real-world reactions to brand collaborations, campaigns, or venue activations. It’s like running a focus group of thousands of your target audience — in minutes.
What sets us apart is accuracy. Our AI consumers are built and continuously refined using real human data, and validated against live human panels to ensure real-world reliability. They evolve their opinions with what’s happening in culture and the market — just like people do.
We recently achieved 93% accuracy compared to live human responses — proving that AI can now match human insight, at scale.
Investor
Sep 2025
Hiverge was founded by former Google DeepMind and University of Cambridge researchers who pioneered the area of AI-driven algorithmic discovery. At Hiverge, we are creating an AI discovery agent to empower every company with superhuman algorithms that drastically optimize their operations.
Contact us to work with us today.
Investor
Jan 2025
We are making biology programmable to transform health and sustainability for the benefit of all.
We are a frontier AI lab building foundational models that capture the fundamentals of biology. We empower partners with breakthrough generative AI to gain unprecedented control over molecular biology, creating new antibodies, optimizing existing enzymes, and advancing genetic engineering.
Contact us to work with us today.
Investor
Aug 2023
Nectar Social is an agentic community management and social listening platform for the worlds leading businesses.
Board Observer
Apr 2023
NomadGo, an innovator in inventory management, has combined computer vision technology and augmented reality to digitize any space.
Whether streamlining inventory counts or transforming the supply chain with automated ordering, Nomad Go’s innovative platform powers business decisions.
Board Observer
Feb 2023
Variational AI has developed Enki, the industrys first commercially available foundation model for small-molecule drug discovery. Enki is based on a novel generative AI framework invented by Variational AI that has delivered novel and selective leads to multiple biopharma partners and customers.
Experience · 12 entries
All (12)
Investments (9)
Founder (1)
Board (2)
2026
Investor
Jan 2026
Aisy’s AI-native threat model intelligence platform turns overwhelming vulnerability data into clear, attacker-driven priorities that free up your team to focus on real risk.
Investor + Board
Jan 2026
At AgileRL, we are on a mission to accelerate reinforcement learning for building superhuman artificial intelligence systems. Backed by Fusion Fund, Flying Fish, Octopus Ventures, Counterview Capital and Entrepreneur First.
We believe that reinforcement learning will form a part of every sophisticated AI system of the future. It already impacts the world we live in, from its use in creating LLMs with reasoning capabilities, to enabling autonomous vehicles to make decisions. Reinforcement learning enables AI models to plan and achieve objectives, but currently very few companies or individuals have the resources to leverage this powerful machine learning paradigm.
AgileRL offers Arena, an enterprise-grade reinforcement learning operations (RLOps) platform and a state-of-the-art open-source framework to eliminate these barriers to entry. Our framework has already achieved 10x faster training and hyperparameter optimisation than leading RL libraries. Arena, built on top of our open-source framework, is focused on four key areas - simulation, training, deployment and monitoring.
2025
Investor
Nov 2025
BluePill builds AI consumers — digital twins of real audiences trained on real-world social, survey, and research data — that think, react, and engage like your customers.
Brands use BluePill to get instant consumer insight — to test product concepts and packaging, identify winning creatives, or simulate real-world reactions to brand collaborations, campaigns, or venue activations. It’s like running a focus group of thousands of your target audience — in minutes.
What sets us apart is accuracy. Our AI consumers are built and continuously refined using real human data, and validated against live human panels to ensure real-world reliability. They evolve their opinions with what’s happening in culture and the market — just like people do.
We recently achieved 93% accuracy compared to live human responses — proving that AI can now match human insight, at scale.
Show all 12 entries ↓
Investment activity
2023–2026 · 9 investments
Recent (last 2 years)Earlier
